Primary Outcome: Weight Loss & HbA1c Reduction

Neurovalens, Belfast
Weight Management Study for Type 2 Diabetics taking Insulin

Inclusion Criteria

  • HbA1c of 7% or higher
  • Taking insulin
  • Diagnosis of Type 2 Diabetes
  • Ages 18 to 70
  • Must be able to travel to Neurovalens for study visits
  • Access to Wi-Fi (Study iPod Touch provided)

Exclusion Criteria

  • Diagnosis of Type 1 Diabetes
  • Change of insulin within last 90 days
  • Implanted device
  • Pregnant

Incentives

  • Compensation for travel
  • Modium Slim device to keep upon completion of the trial